Clinical Trials

An NIH-funded research team led by Dr. Vinod Balachandran from Memorial Sloan Kettering Cancer Center (MSKCC) have been developing a personalized mRNA cancer-treatment vaccine approach....

An mRNA vaccine, used in combination with an immune checkpoint inhibitor and chemotherapy after surgery, induced an immune response in half of treated patients with pancreatic cancer, a small phase I trial showed....